Pfizer CEO Albert Bourla introduced Pfizer's COVID-19 vaccine development process through a recently published book called "Moonshot." Every step from the decision to develop a COVID-19 vaccine to clinical trials, large-scale production, and transportation was close to impossible, and it created a miracle with prepared R&D capabilities and judgment.

In April 2020, Pfizer's researchers shared an aggressive plan to complete phase 3 clinical trials of the COVID-19 vaccine by the second half of 2021. But CEO Albert Bourla told employees, "We have to make a vaccine by October this year. And by next year, hundreds of millions of times, not tens of millions, should be able to be vaccinated," he said, calling f